Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
11/2003
11/13/2003US20030212443 Significance of dosimetry in photodynamic therapy of injured arteries
11/13/2003US20030212052 Induction apoptosis
11/13/2003US20030211045 Magnetoliposome composition for targeted treatment of biological tissue and associated methods
11/13/2003US20030211044 Administering palladium-porphyrin complex; irradiation
11/13/2003US20030211035 Emulsion/aggregation polymeric microspheres for biomedical applications and methods of making same
11/13/2003US20030209210 Animal brushes
11/13/2003CA2483785A1 Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia
11/13/2003CA2483552A1 Calicheamicin derivative-carrier conjugates
11/12/2003EP1360896A2 Animal brush
11/12/2003EP1359975A1 Ocular iontophoretic device and method of use
11/12/2003EP1011696B1 Treatment of stress and preconditioning against stress
11/11/2003US6645517 Which absorbs electromagnetic radiation, and uses the energy to trigger drug delivery; for multiples injections; diabetes
11/11/2003US6645464 Loading metal particles into cell membrane vesicles and metal particular use for imaging and therapy
11/06/2003WO2003091694A2 Method for assay of cognition and memory based on low frequency stimulation
11/06/2003WO2003090793A1 Removal of adenine during a process of pathogen reducing blood and blood components
11/06/2003WO2003090744A1 Antibacterial compositions comprising metal phthalocyanine analogues
11/06/2003WO2003090599A2 Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head
11/06/2003WO2003051404A8 Method for inactivating bacteria and leukocytes in thrombocyte suspensions
11/06/2003WO2003034975A3 Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
11/06/2003WO2003032901A3 Pathological tissue detection and treatment employing targeted benzoindole optical agents
11/06/2003WO2002100478A3 Accelerators for increasing the rate of formation of free radicals and reactive oxygen species
11/06/2003US20030208249 Energy-activated targeted cancer therapy
11/06/2003US20030207933 Compositions and methods for increasing the sensitivity of apoptosis-resistant tumor cells to inducers of apoptosis
11/06/2003US20030205454 Fluid mixing and irradiation device and method especially for biological fluids
11/06/2003CA2483635A1 Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head
11/05/2003EP1357946A2 Reduced fluence rate pdt
11/05/2003EP1357945A2 Method to prevent vision loss
11/05/2003EP1357944A2 Perylenequinones for use with immunotherapy agents
11/05/2003EP1357912A2 Photodynamic therapy of occult choroidal neovascularization linked to age-related macular degeneration
11/05/2003CN1454099A Dendrimer-photosensitizer complexes for medical applications
11/04/2003US6642018 Method for inducing a response in one or more targeted cells
11/04/2003US6641798 Tumor-targeted optical contrast agents
10/2003
10/30/2003WO2003089046A1 Method of treating biological materials with translating electrical fields and electrode polarity reversal
10/30/2003WO2003088883A1 Combination of ablation and controlled drug delivery for the tre atment of cancer
10/30/2003WO2003047633A3 Treatment of angiogenesis disorders using targeted nanoparticles
10/30/2003WO2003020309A3 Compound
10/30/2003WO2003005883A3 Skin treatments using blue and violet light
10/30/2003WO2002012131A3 Antioxidants in clusters of structured water
10/30/2003US20030204206 Electrically responsive promoter system
10/30/2003US20030204126 Dosimetry for californium-252 (252Cf) neutron-emitting brachytherapy sources and encapsulation, storage, and clinical delivery thereof
10/30/2003US20030203956 Method of using a cyclooxygenase-2 inhibitor and one or more ornithine decarboxylase inhibitors as a combination therapy in the treatment of neoplasia
10/30/2003US20030203880 Such as methyl-5-aminolevulinate hydrochloride; porphyrins; antitumor agents; anticancer agents
10/30/2003US20030203049 Triterpene compositions and methods for use thereof
10/30/2003US20030201160 Sterilization, neutralization of infectous viruses in blood; removal adenine, exposure to photosentizer
10/30/2003CA2482183A1 Method of treating biological materials with translating electrical fields and electrode polarity reversal
10/29/2003EP1356813A1 Antibacterial compositions comprising metal phthalocyanine analogues
10/29/2003EP0983272B1 A new class of benzoporphyrin derivative photoactive compounds
10/29/2003EP0892632B1 Compositions useful in the phototherapeutic treatment of proliferative skin disorders
10/29/2003EP0680363B1 Apparatus for providing light-activated therapy
10/29/2003CN1125654C Methods of preparing gas and gaseous precursor filled microspheres
10/28/2003US6638924 Metallotexaphyrin derivatives
10/28/2003US6638767 Methods for delivering compounds into a cell
10/23/2003WO2003087411A1 Method to inhibit cell growth using oligonucleotides
10/23/2003WO2003087308A2 Use of interleukin-24 to treat ovarian cancer
10/23/2003WO2003087307A2 Use of interleukin-19 to treat cervical cancer
10/23/2003WO2003086503A2 Electrocardiographic aspects of chf treatment
10/23/2003WO2003086460A2 High fluence rate activation of photosensitizers for dermatological applications
10/23/2003WO2003086312A2 Conjugates comprising cancer cell specific ligands, a sugar and cancer chemotherapeutic agents/boron neutron capture therapy agents, and uses thereof
10/23/2003WO2003086298A2 Use of interleukin-19 to treat ovarian cancer
10/23/2003WO2003086215A1 Low intensity light therapy for the manipulation of fibroblast-derived mammalian cells and collagen
10/23/2003WO2003068929A9 Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors
10/23/2003WO2003032902A3 Tumor targeted photodiagnostic-phototherapeutic agents
10/23/2003WO2003017824A3 Method and apparatus for acne treatment
10/23/2003WO2002100326A3 Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies
10/23/2003WO2002068000A3 Polymeric imagable brachytherapy seed
10/23/2003US20030199449 Combination of ablation and controlled drug delivery for the treatment of cancer
10/23/2003US20030198637 Antiproliferative agent; induction apoptosis; antitumor agents
10/23/2003DE20301916U1 Glass tube is filled with e.g. essences and illuminated by fitting on lamp, rod then being placed in water which is then used for energizing body or itself used for massage
10/23/2003CA2482934A1 Low intensity light therapy for the manipulation of fibroblast-derived mammalian cells and collagen
10/23/2003CA2481519A1 Electrocardiographic aspects of chf treatment
10/23/2003CA2481372A1 Method to inhibit cell growth using oligonucleotides
10/23/2003CA2480213A1 Use of interleukin-19 to treat ovarian cancer
10/23/2003CA2480176A1 Use of interleukin-24 to treat ovarian cancer
10/23/2003CA2479519A1 Use of interleukin-19 to treat cervical cancer
10/22/2003EP1353925A2 Processes for large scale production of tetrapyrroles
10/22/2003EP1353723A2 Ablation of cells using combined electric field and ultrasound therapy
10/22/2003EP1353692A2 Methods and compositions for treatment of ocular neovascularization and neural injury
10/22/2003EP1226221B1 Fluorescent film
10/21/2003US6635417 Complex formation between DSDNA and oligomer of cyclic heterocycles
10/16/2003WO2003039478A3 Method and apparatus for the stimulation of hair growth
10/16/2003WO2002084284A3 Diagnosis and treatment of cancer:ii
10/16/2003WO2002056804A3 Presbyopia treatment by lens alteration
10/16/2003US20030194806 Synthetic media for blood components
10/16/2003US20030194390 Alkyl cyanoacrylate and inhibitor and aggregate structure formed; alkyl fatty ester, opacifier; ablating tissue by blocking blood flow
10/15/2003EP1352073A2 Electrically responsive promoter system
10/15/2003EP0912445B1 Method and device for treating a liquid medium
10/14/2003US6632818 Inhibitors of prenyl-protein transferase
10/09/2003WO2003082267A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
10/09/2003US20030191458 Light-activated drug delivery method and device
10/09/2003US20030191446 Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same
10/09/2003US20030190680 Photocleavable bioreactive agents
10/08/2003EP1349962A1 Methods and compositions for detecting polynucleotide duplex damage
10/08/2003EP1349574A2 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
10/08/2003EP1349547A2 Use of 5-aminolevulinic acid for the prophylaxis of restenosis
10/08/2003EP1227808B1 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation
10/08/2003EP0814719B1 Ultrasound therapy device
10/08/2003CN1447689A Radioprotective agents
10/07/2003US6631283 B/B-like fragment targeting for the purposes of photodynamic therapy and medical imaging
10/07/2003US6630128 Insoluble support
10/07/2003US6629971 Process for stimulating hair growth
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 95